Xtressé Gummy for Hair Loss in Men
Part of Skin clinical trials.
This study tests whether a gummy supplement called Xtressé can help men regrow hair or slow hair loss. You'll take the gummy daily and your hair will be measured over time to see if it improves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 65 years old
- You have moderate to significant hair loss on the top/crown of your head (Norwood III–IV stage)
- You have not started or changed any other hair treatments in the past 3 months
- You do not have uncontrolled health conditions like diabetes or high blood pressure
- You have no history of scalp conditions (like psoriasis or eczema) that could affect the study
- You do not have metabolic syndrome (a group of conditions involving weight, blood sugar, and cholesterol)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily gummy supplement called Xtressé can help with self-perceived thinning hair in women. If you are a woman between 18 and 65 who feels your hair is thinning, this trial may help determine if the supplement is effective for you.
This trial tests whether a combination of a dietary supplement and a topical serum can help women with thinning hair grow thicker, fuller hair. It's designed for women who have noticed mild to moderate hair thinning and want a non-invasive approach.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This trial tests a new gel made from a natural sugar molecule against a standard hair loss treatment (minoxidil). It aims to see which works better for people with mild to moderate hereditary hair loss.
This study looks at a computer-guided system (ARTAS) to move hair follicles to thinning areas to treat male pattern hair loss. You might join if you’re a man with moderate thinning and can follow the study’s hair-cutting and follow-up steps.
This study tests a new experimental biologic treatment, XVIE, for male and female pattern baldness. It aims to see if the treatment is safe and can help regrow hair in people with mild to moderate thinning.
Hear when a new Androgenic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.